MS-DRG 848 — Chemotherapy without Acute Leukemia as Secondary Diagnosis without CC/MCC

MDC 17 · Myeloproliferative Diseases & Neoplasms · Medical DRG · FY2026

FY2026 relative weight	0.8494
Geometric mean LOS	2.6 days
Arithmetic mean LOS	3.3 days
Severity tier	without CC/MCC
Post-acute transfer policy	No
Special payment provision	No

Price DRG 848 at a specific hospital →

Severity family — documentation moves the weight 3.05×

The same base condition splits by coded severity (CC/MCC). Weight deltas here are exactly what one documented comorbidity is worth:

DRG	Title	FY2026 weight	GMLOS
846	Chemotherapy without Acute Leukemia as Secondary Diagnosis with MCC	2.5925	5.8
847	Chemotherapy without Acute Leukemia as Secondary Diagnosis with CC	1.3082	3.8
848	Chemotherapy without Acute Leukemia as Secondary Diagnosis without CC/MCC	0.8494	2.6